Press Releases

MEXICO CITY, Dec. 12, 2019 /PRNewswire/ -- Grupo LALA, S.A.B. de C.V., a Mexican Company focused on healthy and nutritious foods ("LALA", or "the Company") (BMV: "LALAB"), today announced that Grupo LALA and Mauricio Leyva have reached a mutual agreement wherein Mr. Leyva will step down as Chief Executive Officer effective

COLUMBUS, Ohio, Dec. 12, 2019 /PRNewswire/ -- AARP Ohio Advocacy and Communications Manager Luke Russell released the following statement today, applauding Reps. Joyce Beatty, Marcia Fudge, Marcy Kaptur and Tim Ryan

SAN DIEGO, Dec. 12, 2019 /PRNewswire/ -- Chronolife, an artificial intelligence company specializing in digital health, today announced the commercial launch of Nexkin™, a ground

CAPE CANAVERAL, Fla., Dec. 12, 2019 /PRNewswire/ -- A student team from the University of Minnesota rocketed their way to victory and a $25,000 prize in the annual Bayer Alka-Rocket Challenge held here today at Kennedy Space Center Visitor Complex.Experience the interactive Multichannel News Release he

STOCKHOLM, Dec. 12, 2019 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, UNITED KINGDOM, AUSTRALIA, CANADA, JAPAN OR ANY OTHER J

SPRINGFIELD, Ill., Dec. 12, 2019 /PRNewswire/ -- AARP Illinois State Director Bob Gallo released the following statement today, applauding Reps. Cheri Bustos, Sean Casten, Danny K. Davis, Bill Foster,

HARRISBURG, Pa., Dec. 12, 2019 /PRNewswire/ -- AARP Pennsylvania State Director Bill Johnston-Walsh released the following statement today, applauding Reps. Boyle, Cartwright, Dean, Doyle, Evans, Fitzpatrick, Houlahan, Lamb, Scanlon, and Wild of the U.S. House of Representatives for voting to pass H.R. 3, the Elijah E. Cummings Lower D

WINNIPEG, Dec. 12, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH), (OTC: MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the completion of the FABOLUS-FASTER Phase 4 trial, a randomized, open-label, multi-center trial assessing different regimens of intravenous platelet inhibitors, notably tirofiban (an IV GP

LOS ANGELES, Dec. 12, 2019 /PRNewswire/ -- As Johnson & Johnson's flagship product, talcum powder has become an integral part of the personal care culture in the United States. Yet many consumers are unaware of talcum powder's dark history, and the potential risk of ovarian cancer it poses to the women using it daily.

SILVER SPRING, Md., Dec. 12, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today granted accelerated approval to Vyondys 53 (golodirsen) injection to treat Duchenne muscular dystrophy (DMD) patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping. It is estimated that about 8 percent of patients with DMD have th